CR20240004A - Composición farmacéutica de virus no encapsulado - Google Patents

Composición farmacéutica de virus no encapsulado

Info

Publication number
CR20240004A
CR20240004A CR20240004A CR20240004A CR20240004A CR 20240004 A CR20240004 A CR 20240004A CR 20240004 A CR20240004 A CR 20240004A CR 20240004 A CR20240004 A CR 20240004A CR 20240004 A CR20240004 A CR 20240004A
Authority
CR
Costa Rica
Prior art keywords
pharmaceutical composition
compositions
virus
unencapsulated
unencapsulated virus
Prior art date
Application number
CR20240004A
Other languages
English (en)
Spanish (es)
Inventor
Ekaterina Aleksandrovna Lomkova
Aleksandra Aleksandrovna Sozonova
Lina Igorevna Fedorenko
Dmitry Valentinovich Morozov
Aleksandr Olegovich Iakovlev
Marina Konstantinovna Dvoriankina
Original Assignee
Biocad Joint Stock Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2021120143A external-priority patent/RU2860958C2/ru
Application filed by Biocad Joint Stock Co filed Critical Biocad Joint Stock Co
Publication of CR20240004A publication Critical patent/CR20240004A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CR20240004A 2021-07-08 2022-07-04 Composición farmacéutica de virus no encapsulado CR20240004A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2021120143A RU2860958C2 (ru) 2021-07-08 Фармацевтическая композиция безоболочечного вируса
PCT/RU2022/050212 WO2023282796A2 (fr) 2021-07-08 2022-07-04 Composition pharmaceutique de virus non enveloppé

Publications (1)

Publication Number Publication Date
CR20240004A true CR20240004A (es) 2024-06-11

Family

ID=84800844

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20240004A CR20240004A (es) 2021-07-08 2022-07-04 Composición farmacéutica de virus no encapsulado

Country Status (12)

Country Link
EP (1) EP4367252A4 (fr)
CN (1) CN117999353A (fr)
AR (1) AR126417A1 (fr)
CL (1) CL2024000062A1 (fr)
CO (1) CO2024000073A2 (fr)
CR (1) CR20240004A (fr)
EC (1) ECSP24001599A (fr)
JO (1) JOP20240003A1 (fr)
MA (1) MA63861A1 (fr)
MX (1) MX2024000472A (fr)
WO (1) WO2023282796A2 (fr)
ZA (1) ZA202400124B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2026503893A (ja) * 2023-01-19 2026-02-02 ユニキュアー バイオファーマ ビー.ブイ. 遺伝子送達媒体の医薬製剤
CN122029285A (zh) * 2023-09-06 2026-05-12 迪纳柯公司 用aav基因治疗载体和治疗调配物治疗肥厚性心肌病的方法
WO2025114524A1 (fr) * 2023-11-30 2025-06-05 Uniqure Biopharma B.V. Formulations pour produits médicamenteux viraux
WO2025263459A1 (fr) * 2024-06-17 2025-12-26 学校法人神戸薬科大学 Composition biopharmaceutique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012222150A1 (en) * 2011-02-24 2013-09-26 Paxvax, Inc. Formulations useful for spray drying vaccines
US20130216499A1 (en) * 2012-02-17 2013-08-22 Wenlin Huang Compositions of recombinant human endostatin adenovirus injections and methods of production
CN105530917B (zh) * 2013-09-19 2020-06-05 扬森疫苗与预防公司 改进的腺病毒配制品
PT3534922T (pt) * 2016-11-04 2024-06-07 Takeda Pharmaceuticals Co Formulações de vírus adenoassociado
JP2021530548A (ja) * 2018-07-24 2021-11-11 ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics, Inc. 遺伝子治療製剤を生産するための系および方法

Also Published As

Publication number Publication date
CO2024000073A2 (es) 2024-04-29
JOP20240003A1 (ar) 2024-01-08
EP4367252A2 (fr) 2024-05-15
AR126417A1 (es) 2023-10-11
WO2023282796A3 (fr) 2023-02-16
WO2023282796A2 (fr) 2023-01-12
MA63861A1 (fr) 2024-10-31
ECSP24001599A (es) 2024-02-29
CL2024000062A1 (es) 2024-06-14
ZA202400124B (en) 2024-11-27
EP4367252A4 (fr) 2025-04-30
CN117999353A (zh) 2024-05-07
MX2024000472A (es) 2024-02-12

Similar Documents

Publication Publication Date Title
CL2024000062A1 (es) Composición farmacéutica de virus no encapsulado
CL2018003196A1 (es) Cápsides variantes de virus adenoasociados y métodos de uso de estas.
BR112021015751A2 (pt) Vetores de terapia genética para tratamento da doença de danon
MX2021004431A (es) Procesos novedosos.
EA201101518A1 (ru) Фармацевтическая композиция для применения в медицинской и ветеринарной офтальмологии
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
BR112016025997A8 (pt) compostos para tratamento de doenças e lesões oftalmológicas, uma composição farmacêutica e uma formulação oftálmica
WO2015128403A3 (fr) Nouveaux dérivés de l'insuline et leurs utilisations médicales
SA521421715B1 (ar) تركيبات سيماجلوتيد ثابتة واستخداماتها
EP3498279A4 (fr) Composition pharmaceutique comprenant comme principes actifs de l'amodiaquine et un médicament anti-diabète, destinée à la prévention ou le traitement du diabète
EP4477267A3 (fr) Compositions médicamenteuses à base de collagène peptidique pour l'utilisation dans le traitement des maladies, troubles ou blessures oculaires
PH12013501373B1 (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
WO2022192594A3 (fr) Molécules d'acide nucléique et vaccins les comprenant pour la prévention et le traitement d'infections à coronavirus et de maladie
BR112015023806A2 (pt) Novos regimes de dosagem de celgosivir para o tratamento de dengue
EA202090666A1 (ru) Применение содержащей бензоат композиции для лечения глициновой энцефалопатии
PH12022551094A1 (en) Novel insulin analogues and uses thereof
PH12022550238A1 (en) Camphorsulfonic acid and combinations thereof with cationic excipients as viscosity reducing agents in high concentrated protein formulations
CO2023004031A2 (es) Administración sistémica del vector de virus adenoasociado que expresa el sarcoglucano g y el tratamiento de la distrofia muscular
BR112019024796A2 (pt) Peptídeos e usos dos mesmos como agentes antivirais
MX2024009890A (es) Factores terapeuticos para el tratamiento de enfermedades poliglutaminicas
BR112022000417A2 (pt) Proteínas de toxina de fusão para tratamento de doenças relacionadas a infecções por cmv
GEAP202516788A (en) Pharmaceutical composition of non-enveloped virus
BR112017022390A2 (pt) composição farmacêutica
JOP20220313A1 (ar) تركيبة دوائية مائية من الليفيليماب وإستخدامها
MX2024001541A (es) Composiciones proteicas para el tratamiento de enfermedades inflamatorias.